Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Dec;64(6):1139–1144. doi: 10.1038/bjc.1991.478

Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.

P K Lipponen 1, M J Eskelinen 1, S Nordling 1
PMCID: PMC1977863  PMID: 1764378

Abstract

The predictive value of silver stained nucleolar organiser regions (AgNORs) was assessed in 229 patients with transitional cell bladder cancer followed up for over 10 years. The AgNORs were enumerated in pretreatment biopsy specimens. The AgNORs were related to clinical stage (T) (P = 0.0111), papillarity (P less than 0.0001), WHO grade (P less than 0.0001), DNA ploidy (P = 0.0010) and S-phase fraction (P less than 0.0001). Tumours presenting with pelvic lymph node involvement (P = 0.0085) or metastasis (P = 0.0780) at the time of diagnosis had more AgNORs than tumours confined to the bladder wall. Progression in T-, N- and M-categories (P = 0.0010-0.0030) was related to AgNORs and consequently they predicted bladder cancer related survival (P = 0.0005). The diploid tumours could be regrouped according to survival by AgNORs (P = 0.0001). In papillary tumours AgNORs predicted progression (P = 0.0110) and survival (P = 0.0038). In Ta-T1 tumours AgNORs predicted progression (P = 0.11) and survival (P = 0.0751) and also in T2-T3 tumours AgNORs contributed to survival significantly (P = 0.0039). The AgNORs subdivided WHO grade III tumours according to their ability to progress during the follow-up time (P = 0.0711). In a multivariate analysis AgNORs predicted progression independently in Ta-T1 category (P = 0.0165). AgNORs predicted recurrence free period like SPF (P = 0.0010). In conclusion, AgNORs are inferior to classic prognostic factors or DNA flow cytometric variables in muscle invasive bladder cancers whereas they have independent predictive value in superficial cancers.

Full text

PDF
1139

Images in this article

1140Figure 1
on p.1140

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomjous E. C., Schipper N. W., Baak J. P., Vos W., De Voogt H. J., Meijer C. J. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol. 1989 Mar;91(3):243–248. doi: 10.1093/ajcp/91.3.243. [DOI] [PubMed] [Google Scholar]
  2. Cairns P., Suarez V., Newman J., Crocker J. Nucleolar organizer regions in transitional cell tumors of the bladder. Arch Pathol Lab Med. 1989 Nov;113(11):1250–1252. [PubMed] [Google Scholar]
  3. Crocker J., Boldy D. A., Egan M. J. How should we count AgNORS? Proposals for a standardized approach. J Pathol. 1989 Jul;158(3):185–188. doi: 10.1002/path.1711580303. [DOI] [PubMed] [Google Scholar]
  4. Delahunt B., Ribas J. L., Nacey J. N., Bethwaite P. B. Nucleolar organizer regions and prognosis in renal cell carcinoma. J Pathol. 1991 Jan;163(1):31–37. doi: 10.1002/path.1711630107. [DOI] [PubMed] [Google Scholar]
  5. Eskelinen M. J., Lipponen P. K., Collan Y., Syrjänen K. J. The role of nucleolar organiser regions as prognostic factors in breast cancer. Eur J Cancer. 1991;27(8):989–992. doi: 10.1016/0277-5379(91)90265-f. [DOI] [PubMed] [Google Scholar]
  6. Eskelinen M., Lipponen P., Collan Y., Marin S., Alhava E., Nordling S. Relationship between DNA ploidy and survival in patients with exocrine pancreatic cancer. Pancreas. 1991 Jan;6(1):90–95. doi: 10.1097/00006676-199101000-00012. [DOI] [PubMed] [Google Scholar]
  7. Giri D. D., Nottingham J. F., Lawry J., Dundas S. A., Underwood J. C. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry. J Pathol. 1989 Apr;157(4):307–313. doi: 10.1002/path.1711570407. [DOI] [PubMed] [Google Scholar]
  8. Lee E. T., Desu M. M. A computer program for comparing K samples with right-censored data. Comput Programs Biomed. 1972 Nov;2(4):315–321. doi: 10.1016/0010-468x(72)90019-0. [DOI] [PubMed] [Google Scholar]
  9. Lipponen P. K., Eskelinen M. J., Nordling S. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy. Eur J Cancer. 1991;27(7):877–881. doi: 10.1016/0277-5379(91)90138-4. [DOI] [PubMed] [Google Scholar]
  10. Lipponen P. K., Eskelinen M. J., Nordling S. Relationship between DNA flow cytometric data, nuclear morphometric variables and volume-corrected mitotic index in transitional cell bladder tumors. Eur Urol. 1991;19(4):327–331. doi: 10.1159/000473653. [DOI] [PubMed] [Google Scholar]
  11. Lipponen P. K., Eskelinen M. J. Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosis. Anticancer Res. 1991 Jan-Feb;11(1):75–80. [PubMed] [Google Scholar]
  12. Lipponen P. K., Eskelinen M. J., Sotarauta M. Prediction of superficial bladder cancer by histoquantitative methods. Eur J Cancer. 1990;26(10):1060–1063. doi: 10.1016/0277-5379(90)90052-u. [DOI] [PubMed] [Google Scholar]
  13. Lipponen P. K., Eskelinen M. J. Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer. Eur Urol. 1990;18(4):258–262. doi: 10.1159/000463925. [DOI] [PubMed] [Google Scholar]
  14. Lipponen P., Eskelinen M. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading. Anticancer Res. 1990 Nov-Dec;10(6):1725–1730. [PubMed] [Google Scholar]
  15. Mansour P., Crocker J., Newman J. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder. Arch Pathol Lab Med. 1990 Dec;114(12):1261–1261. [PubMed] [Google Scholar]
  16. Ooms E. C., Anderson W. A., Alons C. L., Boon M. E., Veldhuizen R. W. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol. 1983 Feb;14(2):140–143. doi: 10.1016/s0046-8177(83)80242-1. [DOI] [PubMed] [Google Scholar]
  17. Ooms E. C., Veldhuizen R. W. Argyrophilic proteins of the nucleolar organizer region in bladder-tumours. Virchows Arch A Pathol Anat Histopathol. 1989;414(4):365–369. doi: 10.1007/BF00734093. [DOI] [PubMed] [Google Scholar]
  18. Rüschoff J., Bittinger A., Neumann K., Schmitz-Moormann P. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract. 1990 Feb;186(1):85–91. doi: 10.1016/S0344-0338(11)81014-9. [DOI] [PubMed] [Google Scholar]
  19. Rüschoff J., Plate K. H., Contractor H., Kern S., Zimmermann R., Thomas C. Evaluation of nucleolus organizer regions (NORs) by automatic image analysis: a contribution to standardization. J Pathol. 1990 Jun;161(2):113–118. doi: 10.1002/path.1711610205. [DOI] [PubMed] [Google Scholar]
  20. Sivridis E., Sims B. Nucleolar organiser regions: new prognostic variable in breast carcinomas. J Clin Pathol. 1990 May;43(5):390–392. doi: 10.1136/jcp.43.5.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith R., Crocker J. Evaluation of nucleolar organizer region-associated proteins in breast malignancy. Histopathology. 1988 Feb;12(2):113–125. doi: 10.1111/j.1365-2559.1988.tb01923.x. [DOI] [PubMed] [Google Scholar]
  22. Underwood J. C., Giri D. D. Nucleolar organizer regions as diagnostic discriminants for malignancy. J Pathol. 1988 Jun;155(2):95–96. doi: 10.1002/path.1711550203. [DOI] [PubMed] [Google Scholar]
  23. Wachtler F., Hopman A. H., Wiegant J., Schwarzacher H. G. On the position of nucleolus organizer regions (NORs) in interphase nuclei. Studies with a new, non-autoradiographic in situ hybridization method. Exp Cell Res. 1986 Nov;167(1):227–240. doi: 10.1016/0014-4827(86)90219-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES